Press Releases

Bio-Imaging Technologies To Participate In Annual HIMSS Conference In Dallas February 13-17

NEWTOWN, PA, February 10, 2005 -- Bio-Imaging Technologies, Inc. (“Bio-Imaging”) (NASDAQ/NMS: BITI) today announced that its CapMed Division, the cornerstone of Bio-Imaging’s new Personal Health Management Division, will be showcasing its personal health management solutions at the Healthcare Information and Management Systems Society’s (HIMSS) 2005 Annual Conference in Dallas, Texas, February 13-17. This event is touted as the “must attend” conference each year in the health information technology industry. An estimated 20,000 professionals and 700 exhibitors are expected to attend.

CapMed’s core products, the CapMed Personal Health Record™ (PHR) software and the Personal HealthKey™, as well as the new MedicAlert® HealthKey™ will be exhibited and demonstrated at CapMed’s booth (#6918). In addition the Personal HealthKey will be demonstrated at the following locations:

• SanDisk, CapMed’s hardware vendor for the HIMSS show
• GE Healthcare as part of their consumerism promotion.

In addition, CapMed will participate in the Conference’s interoperability showcase. The showcase will demonstrate how clinicians can use interoperable electronic health record (EHR) products and standards to share patient data. The showcase will illustrate this in 4 settings: the home, a small clinic, a multi-specialty practice, and a diagnostic center. A Personal HealthKey branded to CapMed and NextGen Healthcare Information Systems will be distributed by CapMed at the Interoperability Showcase.

At the showcase, attendees will be able to create and manage their own sample electronic health records, including Continuity of Care Records, radiology images, laboratory results, cardiology reports and the information infrastructure to support security. Attendees will then visit select vendor exhibit booths to access or create additional content for their records and see how different companies incorporate Integrating the Healthcare Enterprise (IHE)-and thus interoperability-into their products. In CapMed’s home section, attendees will be able to upload glucose readings from a glucose meter and a blood pressure monitor into their PHR and onto the Personal HealthKey, just as an individual managing a chronic condition at home would do, and will then be able to communicate this information along with any additional self-tracked information via the CapMed secure hub and with the portable HealthKey device to the other participating vendors in this showcase.

Additionally CapMed will be demonstrating the ability for attendees to send and receive Continuity of Care Records from physician record systems through the secure hub or via a USB port using the Personal HealthKey. CapMed will also enable attendees to securely receive and store an ECG in medical diagnostic quality to the patients PHR, tied to the cardiac condition for which it relates, and linked to pertinent patient education.

CapMed’s Personal HealthKey fits on a key chain and is a simple, reliable, secure and cost-effective portable solution for people to easily take specific health reports or their entire medical record, including images, anywhere. The HealthKey plugs into a computer’s USB port, allowing doctors and patients easy access to the patient’s medical record without the need for additional hardware or software, and is line with HIPAA guidelines by enabling the patient to encrypt and password protect as much or as little of their medical record as they would like.

The PHR is an award-winning, cost-efficient software application that enables users to manage and store personal health information, including their medical images, on the privacy of his/her desktop computer, while linking directly to sponsor-directed resources such as drug information, patient education, or disease guidelines. This award-winning program is an industry leader with more than 400,000 distributed.

For further information on the HIMSS conference, visit the HIMSS website at www.himss.org.

About CapMed

CapMed, a division of Bio-Imaging Technologies, Inc., (NASDAQ/NMS: BITI - News) is based in Newtown, PA. The CapMed Personal Health Record™ (PHR) and Personal HealthKey™ provide hospitals and health systems, employers and pharmaceutical organizations with custom personal health management solutions and marketing tools to increase market share, reduce costs of care, improve patient-provider communications, and empower patients to be more active in personal health management. This is accomplished through a combination of personal health management tools, personalized education, and links to relevant community resources.

About Bio-Imaging

Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its US Core Lab (Newtown PA), European Core Lab (Leiden, The Netherlands) and U.S. Business Offices (Massachusetts and California). Through its recently acquired CapMed division, Bio-Imaging provides the Personal HealthKey™ technology and the Personal Health Record™ (PHR) software allowing patients to better monitor and manage their health care information.

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.